SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
308 hedge funds and large institutions have $8.26B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 109 increasing their positions, 127 reducing their positions, and 46 closing their positions.
144% more call options, than puts
Call options by funds: $199M | Put options by funds: $81.4M
21% more capital invested
Capital invested by funds: $6.82B → $8.26B (+$1.43B)
1% more funds holding
Funds holding: 304 → 308 (+4)
9% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 46
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
14% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 127
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$148M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$119M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$92.8M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$58.2M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$50.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$132M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$78M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$46.7M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$39.1M |
| 5 |
Bank of New York Mellon
New York
|
-$38.7M |
SLXP Hedge Fund Activity: Q2 2014 in Review
308 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2014, worth a combined $8.26B — up 21% from $6.82B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new SLXP positions and 46 closed out — a net gain of 4 holders — while 109 added to existing stakes and 127 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $148M. The largest seller was Fidelity Investments, cutting an estimated $132M.
- 308 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2014, up from 304 in Q1 2014.
- Funds reported $8.26B of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2014, up 21% quarter-over-quarter.
- 50 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2014 and 46 closed out, a net change of +4 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q2 2014 was Viking Global Investors, an estimated $148M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2014 was Fidelity Investments, an estimated $132M sold.
Based on aggregated 13F filings for Q2 2014.